Trontinemab is one of a class of new medicines aimed at clearing amyloid plaques. The new findings from phase two trials ...

As you age, maintaining a daily habit of walking can prevent cognitive decline, especially for those most at risk, a new ...

A cancer drug that has already been approved by the US Food and Drug Administration (FDA) could also help people with ...

Families across Georgia are finding new hope in the fight against Alzheimer’s disease, thanks to promising treatments at ...

Because Alzheimer’s is just one of several diseases that cause dementia, the key distinction lies in their scope. “Alzheimer’s disease is a specific condition resulting from an abnormal biological ...

Roche Holding AG plans to test whether an experimental medicine can prevent Alzheimer’s disease symptoms in high-risk people, ...

The brain's health depends on more than just its neurons. A complex network of blood vessels and immune cells acts as the ...

Research has suggested that about 40% of dementia cases could be prevented or delayed by addressing 14 modifiable risk factors — alcohol abuse, smoking, diabetes, obesity, high ...

There’s good news for older Americans at high-risk of developing dementia: simple steps to stay mentally and physically ...

New research builds on previous evidence that diet, certain brain training exercises and physical activity can delay the decline of memory and other cognitive abilities.

In a Phase Ib/IIa trial, 91% of patients receiving the highest dose of trontinemab were amyloid negative after seven months of treatment, representing what B. Riley Securities called a “paradigm shift ...

Individuals treated for breast cancer often develop cognitive issues, but they may have a lower risk for developing Alzheimer ...